Roche trial for COVID-19 pill delayed in UK as vaccine rollout intervened


FILE PHOTO: A sign at a diagnostics site for Swiss pharmaceutical giant Roche is seen, in Burgess Hill, Britain, October 7, 2020. REUTERS/Peter Nicholls

ZURICH (Reuters) - Swiss drugmaker Roche's trial of a pill against COVID-19 in Britain has been delayed as the vaccine rollout in that country made it tough to find patients for its Phase 2 study, the company's drugs division chief said on Wednesday.

Drugs chief Bill Anderson said that Roche is now lining up additional clinical trial sites in hopes of getting the programme on track for the pill, an antiviral oral treatment called AT-527 that Roche is developing with Atea Pharmaceuticals.

(Reporting by John Miller; Editing by Michael Shields)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
   

Next In World

Prosecutors shelve case over Cairo hotel gang rape allegation for 'insufficent evidence'
Two killed as protesters mark anniversary of massacre -medics, protest group
U.N. Yemen envoy Griffiths tapped to be U.N. aid chief - sources
Turkey says dialogue on disputes with Saudi Arabia to continue
Netanyahu says Gaza militants will pay 'very heavy price' over rocket fire
U.S. puts brake on U.N. statement over Middle East tensions
Cameroonian transgender women convicted of 'attempted homosexuality'
'Want the COVID-19 vaccine? Have a U.S. visa?' Latinos travel north for the shot
White House condemns attacks on Israel, calls for co-existence in Jerusalem
Mexico's president backs probe of opposition governor candidates

Stories You'll Enjoy


Vouchers